drugset / Trial / NCT03060434
Pentoxifylline and Lumbar Radiculopathy
RandomizedCrossoverDouble-blindTreatment
Summary
The objective of this prospective controlled crossover study is to evaluate the efficacy and safety of pentoxifylline per os (800 mg daily) in the management of lumbar radiculopathy
Timeline
- Start
- 2018-06-01
- Primary completion
- 2022-12-01
- Completion
- 2026-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pentoxifylline | Small molecule | 400 mg | Oral |
| Background | Acetaminophen | Small molecule | 1 g | — |
| Comparator | Ibuprofen | Small molecule | 600 mg | — |
| Background | Pregabalin | Small molecule | 75 mg | — |